Glipizide and Metformin Hydrochloride NDC 0093-7455

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-7455Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-7455Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-7455-01	00093745501	100 TABLET, FILM COATED in 1 BOTTLE (0093-7455-01)Marketed from Oct 28, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glipizide and Metformin Hydrochloride
Generic name (nonproprietary): glipizide and metformin hydrochloride
Active ingredients: Glipizide — 2.5 mg/1Metformin hydrochloride — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077270
Marketing start: Oct 28, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Biguanides (Chemical structure)Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 0093-7455_7d659eb2-cee9-4326-a439-ef5ec9ec9c63SPL ID 7d659eb2-cee9-4326-a439-ef5ec9ec9c63SPL set ID 03d9ce02-0559-494c-a53d-de9b9a64b606RxCUI 861731, 861736, 861740UNII 786Z46389E, X7WDT95N5CUPC 0300937455011, 0300937456018, 0300937457015
Pharmacologic class: Biguanide; Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093745501 followed by a unit qualifier and the quantity

Package 00093-7455-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Glipizide and metformin hydrochloride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077270

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077270
Product	Strength	Form · route	Labeler	Product NDC
Glipizide and Metformin Hydrochloride	Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	AvKARE	42291-305
Glipizide and Metformin Hydrochloride	Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	AvKARE	42291-306
Glipizide and Metformin Hydrochloride	Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-7456
Glipizide and Metformin Hydrochloride	Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-7457
Glipizide and Metformin Hydrochloride	Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-0373